Quick Answer
TherapeuticsMD, Inc. reported Shares Outstanding of 11.57 million shares for fiscal year 2025.
TherapeuticsMD, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 11.57M | +0.4% |
| 2024 | 11.53M | +0.0% |
| 2023 | 11.53M | +21.4% |
| 2022 | 9.50M | +10.5% |
| 2021 | 8.60M | -97.1% |
| 2020 | 299.76M | +10.5% |
| 2019 | 271.18M | +12.8% |
| 2018 | 240.46M | +11.1% |
| 2017 | 216.43M | +10.0% |
| 2016 | 196.69M | +10.5% |
| 2015 | 177.93M | +14.0% |
| 2014 | 156.10M | +7.7% |
| 2013 | 144.98M | +45.3% |
| 2012 | 99.78M | +20.3% |
| 2011 | 82.98M | +41.7% |
| 2011 | 58.57M | +35215.7% |
| 2011 | 165,856 | -99.7% |
| 2010 | 55.49M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 11.57M | +0.4% | +0.0% |
| June 30, 2025 | 11.57M | +0.4% | +0.0% |
| March 31, 2025 | 11.57M | +0.4% | +0.4% |
| December 31, 2024 | 11.53M | +0.0% | +0.0% |
| September 30, 2024 | 11.53M | +9.0% | +0.0% |
| June 30, 2024 | 11.53M | +9.0% | +0.0% |
| March 31, 2024 | 11.53M | +20.8% | +0.0% |
| December 31, 2023 | 11.53M | +21.4% | +9.0% |
- TherapeuticsMD, Inc. showed an increase of +0.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, TherapeuticsMD, Inc.’s shares outstanding has declined by 79.1% (from 55.49 million shares to 11.57 million shares).
- The most recent figure is from TherapeuticsMD, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: